Analyst Ratings February 19, 2026

Goldman Sachs Lifts Molson Coors Target to $50 Amid Mixed Q4 Results and Weak Guidance

Analyst sees lower estimates ahead but flags a potential buying opportunity if the stock retreats

By Marcus Reed TAP
Goldman Sachs Lifts Molson Coors Target to $50 Amid Mixed Q4 Results and Weak Guidance
TAP

Goldman Sachs raised its price target for Molson Coors Beverage Co. (TAP) to $50 from $47 and kept a Buy rating after the company reported mixed fourth-quarter results and issued fiscal 2026 guidance that disappointed investors. The broker expects estimates to move lower following weaker-than-expected guidance and flagged temporary cost pressures and soft demand as headwinds. Despite these concerns, management share repurchases and an attractive free cash flow yield inform Goldman’s view that a pullback could offer a buying entry.

Key Points

  • Goldman Sachs raised its price target on Molson Coors to $50 from $47 and maintained a Buy rating, even though the target is below the current share price of $50.82.
  • Molson Coors reported mixed Q4 results - adjusted EPS beat at $1.21 versus $1.16 expected, but revenue missed at $2.66 billion versus $2.72 billion consensus and fell 2.7% year over year.
  • Analysts expect estimates to move lower after guidance for fiscal 2026 disappointed; eight analysts have already revised earnings downward. Financial health is rated as "FAIR" while free cash flow yield stands at 11% and dividend yield is 3.7%.

Analyst move and market context

Goldman Sachs increased its 12-month price target on Molson Coors Beverage Co. (TAP) to $50 from $47 while retaining a Buy rating. The revised target sits below the stock's most recent trading level of $50.82. Independent valuation data cited by the company suggests the shares may still trade below their assessed fair value.

Drivers behind the change

The target bump follows Molson Coors' mixed fourth-quarter performance and fiscal 2026 guidance that came in below market expectations. Goldman Sachs pointed to a challenging demand backdrop across the industry and a set of temporary cost headwinds - notably elevated Midwest premium aluminum costs - that contributed to the underwhelming top-line performance. Over the last twelve months Molson Coors’ revenue has declined by 4.01%.

Earnings and revenue specifics

For the fourth quarter the company reported adjusted earnings of $1.21 per share, which exceeded the analyst consensus of $1.16. However, quarterly revenue of $2.66 billion missed the $2.72 billion consensus and represented a 2.7% decline year over year. The company’s fiscal 2026 guidance also disappointed investors, with management highlighting significant commodity inflation as a potential headwind.

Analyst expectations and revisions

Goldman Sachs said Street expectations were already modest ahead of the earnings release, but the guidance fell notably short of incoming assumptions. The firm expects analyst estimates will likely be revised materially lower in response. Supporting that outlook, eight analysts have already lowered their earnings projections for the upcoming period according to available revisions data. Those downward adjustments, combined with pressured fourth-quarter results, are likely to weigh on the stock near term.

Balance-sheet and cash-generation signals

Data on the company’s financial profile rates Molson Coors' financial health as "FAIR," while its relative value metrics look stronger than several other financial-health indicators. Management has been an active buyer of shares, and the company currently offers a strong free cash flow yield of 11%. Molson Coors has also sustained dividend payments for 51 consecutive years and currently yields 3.7%.

Goldman Sachs' positioning

Goldman Sachs views the recent results and guidance as a potential opportunity to reset investor expectations down to a more achievable level. The firm is encouraged by management initiatives aimed at reaccelerating sustainable growth, but it cautioned that execution and improvements specifically in the beer category will be critical to achieving medium-term targets. Goldman acknowledged those targets could be challenging given the present industry pressures and the company’s recent performance, and that investors may react skeptically.

Investor takeaway

Goldman Sachs' unchanged Buy rating paired with a higher target reflects a guarded optimism: the bank raised its estimate of where the stock could trade in a year but still prices that target below current market levels. The combination of weaker guidance, analyst estimate downgrades, commodity-driven cost pressures, and declining revenue contrasts with attractive cash-generation metrics and ongoing shareholder returns. Investors evaluating Molson Coors will need to weigh near-term demand and cost uncertainties against the company's cash flow profile and capital returns.


Note on data - The article references contemporaneous analyst revisions, valuation assessments, cash flow yield, and dividend history as reported alongside the company's quarterly release and subsequent analyst commentary.

Risks

  • Guidance shortfall and analyst downgrades - the fiscal 2026 outlook came in below expectations and several analysts have reduced earnings estimates, which may pressure the stock - impacts equity investors and consumer staples sector sentiment.
  • Commodity and input-cost pressures - elevated Midwest premium aluminum costs and broader commodity inflation could continue to weigh on margins and revenue recovery - impacts cost structure and margins in the beverages and packaging supply chains.
  • Demand weakness - the company faces a difficult industry demand environment that contributed to revenue declines over the past year, creating uncertainty for near-term top-line recovery - impacts sales volumes across the beverage sector and related distribution networks.

More from Analyst Ratings

DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026 BWS Financial Boosts A10 Networks Price Target Citing AI-Driven Network Traffic Feb 20, 2026